These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 27232923

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE.
    Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Wynne J, ADHERE Scientific Advisory Committee and Investigators.
    Am J Cardiol; 2008 Jan 15; 101(2):231-7. PubMed ID: 18178412
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.
    Feola M, Aspromonte N, Canali C, Ceci V, Giovinazzo P, Milani L, Quarta G, Ricci R, Scardovi AB, Uslenghi E, Valle R.
    Am J Cardiol; 2005 Sep 01; 96(5):705-9. PubMed ID: 16125500
    [Abstract] [Full Text] [Related]

  • 24. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M, Makhoul BF, Tobia A, Jarous M, Kaplan M, Aronson D, Saliba W, Azzam ZS.
    Am J Emerg Med; 2014 Jan 01; 32(1):44-9. PubMed ID: 24210886
    [Abstract] [Full Text] [Related]

  • 25. Post-discharge rise in BNP and rehospitalization for heart failure.
    Omar HR, Guglin M.
    Herz; 2019 Aug 01; 44(5):450-454. PubMed ID: 29516117
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. An Admission-to-Discharge BNP Increase Is a Predictor of Six-Month All-Cause Death in ADHF Patients: Inferences from Multivariate Analysis Including Admission BNP and Various Clinical Measures of Congestion.
    De Vecchis R, Ariano C, Baldi C.
    J Clin Med; 2016 Nov 10; 5(11):. PubMed ID: 27834898
    [Abstract] [Full Text] [Related]

  • 28. Extent of jugular venous distension and lower extremity edema are the best tools from history and physical examination to identify heart failure exacerbation.
    Omar HR, Guglin M.
    Herz; 2018 Dec 10; 43(8):752-758. PubMed ID: 28993841
    [Abstract] [Full Text] [Related]

  • 29. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 30. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.
    Coiro S, Rossignol P, Ambrosio G, Carluccio E, Alunni G, Murrone A, Tritto I, Zannad F, Girerd N.
    Eur J Heart Fail; 2015 Nov 17; 17(11):1172-81. PubMed ID: 26417699
    [Abstract] [Full Text] [Related]

  • 31. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias.
    Levine YC, Rosenberg MA, Mittleman M, Samuel M, Methachittiphan N, Link M, Josephson ME, Buxton AE.
    Heart Rhythm; 2014 Jul 17; 11(7):1109-16. PubMed ID: 24837348
    [Abstract] [Full Text] [Related]

  • 32. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
    Ben-Dor I, Minha S, Barbash IM, Aly O, Dvir D, Deksissa T, Okubagzi P, Torguson R, Lindsay J, Satler LF, Pichard AD, Waksman R.
    Am J Cardiol; 2013 Aug 15; 112(4):574-9. PubMed ID: 23683951
    [Abstract] [Full Text] [Related]

  • 33. The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure.
    Shah MR, Califf RM, Nohria A, Bhapkar M, Bowers M, Mancini DM, Fiuzat M, Stevenson LW, O'Connor CM.
    J Card Fail; 2011 Aug 15; 17(8):613-21. PubMed ID: 21807321
    [Abstract] [Full Text] [Related]

  • 34. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.
    Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC.
    J Am Coll Cardiol; 2004 Feb 18; 43(4):635-41. PubMed ID: 14975475
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical and Prognostic Significance of Positive Hepatojugular Reflux on Discharge in Acute Heart Failure: Insights from the ESCAPE Trial.
    Omar HR, Guglin M.
    Biomed Res Int; 2017 Feb 18; 2017():5734749. PubMed ID: 28316980
    [Abstract] [Full Text] [Related]

  • 37. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function.
    Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U.
    Am J Med Sci; 2013 Mar 18; 345(3):211-7. PubMed ID: 23422653
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased perioperative b-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery.
    Fox AA, Nascimben L, Body SC, Collard CD, Mitani AA, Liu KY, Muehlschlegel JD, Shernan SK, Marcantonio ER.
    Anesthesiology; 2013 Aug 18; 119(2):284-94. PubMed ID: 23695172
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.